The Health Economics & Outcomes Research Summit is a focused intimate gathering of HEOR professionals, moving past basic introductions to advanced tactical and strategic conversations best leveraging innovative methods to demonstrate the value proposition of new drugs to secure formulary and market access.

Hear cutting-edge case studies into evidence generation, modeling and real-world evidence across oncology, neurology, cardiovascular, rare diseases, and beyond. Explore how leading pharma and pioneering biotechs are navigating this changing landscape including: 

• Adapting value assessments for evolving reimbursement requirements
• Adjusting to price control mechanisms implemented by the Inflation Reduction Act
• Leveraging advances AI to revolutionize data-driven decision-making 

Join this gathering of HEOR experts and gain strategic and commercial market intelligence by exploring how thought leaders are redefining a robust strategy to demonstrate the clinical effectiveness, safety, and cost-effectiveness of new drugs, don’t miss out on your opportunity to fortify a resilient decision-making framework. 

To know more visit: https://bit.ly/3PTp5M4